Phaim Pharma Ltd.
Records under this name other than the patents Phaim Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 2 of 2 · Back to Phaim Pharma Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,735,359 | Combinations of modalities for the treatment of diabetes Lapsed on the fee record Ended May 27, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 27, 2026 | From the USPTO record |
| US 11,286,303 | CTLA4 Fusion Proteins for the Treatment of Diabetes Lapsed on the fee record Ended Mar 29, 2026 · Low confidence | Lapsed on the fee record | Ended Mar 29, 2026 | Low confidence |